Iitaka M, Kawasaki S, Sakurai S, Hara Y, Kuriyama R, Yamanaka K, Kitahama S, Miura S, Kawakami Y, Katayama S
Department of Internal Medicine 4, Saitama Medical School, Japan.
Clin Endocrinol (Oxf). 1998 Jun;48(6):739-46. doi: 10.1046/j.1365-2265.1998.00419.x.
Serum thyroid hormone concentrations in patients with chronic renal failure are usually low, despite normal serum TSH levels. We investigated the effect on thyroid hormone assays of serum dialysable organic acids that are elevated in uraemic patients.
Serum samples from 42 patients with chronic renal failure who were receiving haemodialysis and 37 sex- and age-matched healthy subjects were examined.
Serum thyroid hormone concentrations were measured with an analogue radioimmunoassay (RIA), a labelled antibody assay, and an equilibrium dialysis/RIA method. Serum concentrations of organic acids were determined with high performance liquid chromatography.
Serum thyroid hormone levels determined by an analogue RIA and a labelled antibody assay in uraemic patients increased, and serum concentrations of organic acids decreased following haemodialysis. A significant association existed between serum free T3 (FT3) levels determined by an analogue RIA and serum concentrations of indoxyl sulphate (IS) prior to dialysis. There was also a significant association between serum free T4 (FT4) levels determined by an analogue RIA and serum concentration of IS and hippuric acid (HA) prior to dialysis. There was a significant association between the changes of serum concentrations of indole acetic acid (IAA) and FT4 concentrations prior to and following haemodialysis when determined by an analogue RIA. Serum FT3 and FT4 levels significantly decreased after the addition of IS to serum from healthy subjects when determined by an analogue RIA but not by a labelled antibody assay. Serum FT4 levels, but not FT3 levels, decreased after addition of IAA when determined by an analogue RIA. Serum FT4 concentrations determined by an equilibrium dialysis/RIA were significantly higher than those determined by the other two methods. The addition of IS, IAA, and HA to serum samples from healthy subjects significantly increased FT4 concentrations when determined by an equilibrium dialysis/RIA method.
Increased serum levels of indoxyl sulphate, indole acetic acid and hippuric acid in sera of uraemic patients may interfere with thyroid hormone measurements when an analogue radioimmunoassay is used. In contrast, there was little Interference with a labelled antibody assay. Dialysable organic acids may also interfere with thyroid hormone assays determined by an equilibrium dialysis/radioimmunoassay method.
慢性肾衰竭患者血清甲状腺激素浓度通常较低,尽管血清促甲状腺激素(TSH)水平正常。我们研究了尿毒症患者中升高的血清可透析有机酸对甲状腺激素检测的影响。
检测了42例接受血液透析的慢性肾衰竭患者以及37例性别和年龄匹配的健康受试者的血清样本。
采用模拟放射免疫分析(RIA)、标记抗体分析和平衡透析/RIA方法测定血清甲状腺激素浓度。用高效液相色谱法测定有机酸的血清浓度。
尿毒症患者经模拟RIA和标记抗体分析测定的血清甲状腺激素水平升高,血液透析后血清有机酸浓度降低。透析前,模拟RIA测定的血清游离T3(FT3)水平与硫酸吲哚酚(IS)的血清浓度之间存在显著关联。透析前,模拟RIA测定的血清游离T4(FT4)水平与IS和马尿酸(HA)的血清浓度之间也存在显著关联。模拟RIA测定时,血液透析前后血清吲哚乙酸(IAA)浓度变化与FT4浓度之间存在显著关联。模拟RIA测定时,向健康受试者血清中添加IS后,血清FT3和FT4水平显著降低,但标记抗体分析未出现此情况。模拟RIA测定时,添加IAA后血清FT4水平降低,但FT3水平未降低。平衡透析/RIA测定的血清FT4浓度显著高于其他两种方法测定的结果。采用平衡透析/RIA方法时,向健康受试者血清样本中添加IS、IAA和HA后,FT4浓度显著升高。
尿毒症患者血清中硫酸吲哚酚、吲哚乙酸和马尿酸水平升高,使用模拟放射免疫分析时可能会干扰甲状腺激素检测。相比之下,对标记抗体分析几乎没有干扰。可透析有机酸也可能干扰平衡透析/放射免疫分析方法测定的甲状腺激素检测。